Need for circumspection in prescribing tumor necrosis factor inhibitors and other biologic response modifiers

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

2000 • 1,757 citations

The mortality of rheumatoid arthritis

1994 • 1,323 citations

The development of disability in rheumatoid arthritis

1986 • 317 citations

Extra-articular rheumatoid arthritis: prevalence and mortality

1999 • 271 citations

Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis

2000 • 235 citations

Reduction in long‐term disability in patients with rheumatoid arthritis by disease‐modifying antirheumatic drug–based treatment strategies

1996 • 201 citations

Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept

2001 • 129 citations

Experience with etanercept in an academic medical center: Are infection rates increased?

2002 • 122 citations

Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.

1998 • 121 citations

Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis

1990 • 121 citations

Consensus recommendations for the assessment and treatment of rheumatoid arthritis.

2001 • 67 citations

Current Treatment Strategies for Rheumatoid Arthritis

2000 • 45 citations

Modeling the lifetime costs of rheumatoid arthritis.

1999 • 37 citations

Early aggressive DMARD therapy: The key to slowing disease progression in rheumatoid arthritis

1999 • 32 citations

TNF-α Inhibition: The Need for a Tumor Necrosis Factor Thermostat

2001 • 10 citations

Historical overview of the treatment of rheumatoid arthritis with an emphasis on methotrexate.

1996 • 8 citations